Oragenics

OGENNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.481 M

$0.55 +1.18%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$984.2M

Loss-making

Shares outstanding

4,336,029

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#491GRI BioGRI$2.60M
#492Artelo BiosciencesARTL$2.51M
#493OragenicsOGEN$2.48M
#494Purple BiotechPPBT$2.33M
#495Decoy TherapeuticsDCOY$2.32M

Where these numbers come from

Share counts and financials for Oragenics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.